GR76863B - - Google Patents

Info

Publication number
GR76863B
GR76863B GR69093A GR820169093A GR76863B GR 76863 B GR76863 B GR 76863B GR 69093 A GR69093 A GR 69093A GR 820169093 A GR820169093 A GR 820169093A GR 76863 B GR76863 B GR 76863B
Authority
GR
Greece
Application number
GR69093A
Other languages
Greek (el)
Inventor
Edward Lunt
Malcolm Francis Graham S Stone
Kenneth Robert Harr Wooldridge
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of GR76863B publication Critical patent/GR76863B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GR69093A 1981-08-24 1982-08-23 GR76863B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24

Publications (1)

Publication Number Publication Date
GR76863B true GR76863B (en:Method) 1984-09-04

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
GR69093A GR76863B (en:Method) 1981-08-24 1982-08-23

Country Status (29)

Country Link
JP (1) JPS5843975A (en:Method)
KR (1) KR890000094B1 (en:Method)
AT (1) AT380256B (en:Method)
AU (1) AU571430B2 (en:Method)
BE (1) BE894175A (en:Method)
CA (1) CA1197247A (en:Method)
CH (1) CH655114A5 (en:Method)
DE (2) DE19975037I2 (en:Method)
DK (1) DK161147C (en:Method)
ES (1) ES8400438A1 (en:Method)
FI (1) FI73434C (en:Method)
FR (1) FR2511679A1 (en:Method)
GB (1) GB2104522B (en:Method)
GE (1) GEP19960641B (en:Method)
GR (1) GR76863B (en:Method)
HU (1) HU186107B (en:Method)
IE (1) IE53408B1 (en:Method)
IL (1) IL66606A (en:Method)
IT (1) IT1152505B (en:Method)
LT (1) LT2436B (en:Method)
LU (1) LU84347A1 (en:Method)
LV (2) LV5511A3 (en:Method)
NL (2) NL192739C (en:Method)
NZ (1) NZ201668A (en:Method)
OA (1) OA07174A (en:Method)
SE (1) SE448543B (en:Method)
SU (1) SU1447284A3 (en:Method)
UA (1) UA5971A1 (en:Method)
ZA (1) ZA826120B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
FR2531958B1 (fr) * 1982-08-17 1986-10-31 May & Baker Ltd Nouveaux derive
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
HUP9802536A3 (en) * 1995-09-25 2000-02-28 Sanofi Aventis U S Llc Bridgew Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
EP1706407A2 (en) * 2003-12-30 2006-10-04 Chemagis Ltd. Novel crystalline forms of temozolomide
US20090036435A1 (en) 2005-01-21 2009-02-05 Astex Therapeutics Limited Pharmaceutical Compounds
PE20080695A1 (es) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラa選択的阻害作用を有する新規アミノピリジン誘導体
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
WO2009054332A1 (ja) 2007-10-23 2009-04-30 Banyu Pharmaceutical Co., Ltd. ピリドン置換ジヒドロピラゾロピリミジノン誘導体
PE20091101A1 (es) * 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
CN102256978A (zh) * 2008-11-24 2011-11-23 利莱恩斯生命科学有限公司 制备四嗪衍生物的工艺
WO2010101734A1 (en) 2009-03-06 2010-09-10 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
ES2583006T3 (es) 2009-06-23 2016-09-16 Pharminox Limited Compuestos de 3-sustituido-8-sustituido-3H-imidazo[5,1-d][1,2,3,5-tetrazin-4-ona y su uso
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
MY199967A (en) 2016-03-15 2023-11-30 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of solid tumors
KR101847342B1 (ko) * 2017-05-08 2018-04-11 (주)센텍코리아 웨어러블 체지방 연소량 측정기

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (de) * 1979-08-09 1981-02-26 Basf Ag Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen

Also Published As

Publication number Publication date
NL192739B (nl) 1997-09-01
SU1447284A3 (ru) 1988-12-23
CA1197247A (fr) 1985-11-26
AU8749382A (en) 1983-03-03
DE3231255C2 (en:Method) 1992-02-27
NL192739C (nl) 1998-01-06
LU84347A1 (fr) 1983-06-07
FI822921L (fi) 1983-02-25
NL8203286A (nl) 1983-03-16
ES515176A0 (es) 1983-11-01
DK377882A (da) 1983-02-25
IE53408B1 (en) 1988-11-09
ATA319182A (de) 1985-09-15
CH655114A5 (fr) 1986-03-27
ZA826120B (en) 1983-07-27
DK161147B (da) 1991-06-03
LV5511A3 (lv) 1994-03-10
GB2104522A (en) 1983-03-09
GEP19960641B (en) 1996-11-15
UA5971A1 (uk) 1994-12-29
DE19975037I2 (de) 2001-06-13
OA07174A (fr) 1984-04-30
AT380256B (de) 1986-05-12
FR2511679B1 (en:Method) 1985-02-01
KR840001175A (ko) 1984-03-28
LT2436B (lt) 1994-02-15
IT1152505B (it) 1987-01-07
IT8222938A0 (it) 1982-08-23
FR2511679A1 (fr) 1983-02-25
SE8204817D0 (sv) 1982-08-23
FI73434B (fi) 1987-06-30
DK161147C (da) 1991-11-18
IL66606A (en) 1987-07-31
JPH045029B2 (en:Method) 1992-01-30
FI73434C (fi) 1987-10-09
SE448543B (sv) 1987-03-02
NZ201668A (en) 1985-08-16
BE894175A (fr) 1983-02-23
KR890000094B1 (ko) 1989-03-07
ES8400438A1 (es) 1983-11-01
IT8222938A1 (it) 1984-02-23
IL66606A0 (en) 1982-12-31
LV5621A3 (lv) 1994-05-10
GB2104522B (en) 1985-06-12
FI822921A0 (fi) 1982-08-23
NL990010I1 (nl) 1999-07-01
SE8204817L (sv) 1983-02-25
DE3231255A1 (de) 1983-03-03
HU186107B (en) 1985-06-28
AU571430B2 (en) 1988-04-21
IE822026L (en) 1983-02-24
JPS5843975A (ja) 1983-03-14
NL990010I2 (nl) 1999-09-01

Similar Documents

Publication Publication Date Title
FR2501229B1 (en:Method)
FR2501313B1 (en:Method)
FR2501380B1 (en:Method)
FR2500564B1 (en:Method)
IN154984B (en:Method)
FR2501232B1 (en:Method)
FR2511679B1 (en:Method)
FR2500937B1 (en:Method)
FR2498375B3 (en:Method)
FR2500243B1 (en:Method)
FR2501318B1 (en:Method)
FR2500558B1 (en:Method)
FR2497989B1 (en:Method)
FR2500741B1 (en:Method)
FR2497698B1 (en:Method)
FR2500679B3 (en:Method)
FR2497792B1 (en:Method)
FR2501097B1 (en:Method)
FR2497561B1 (en:Method)
DE3152800C2 (en:Method)
FR2497509B1 (en:Method)
FR2501022B3 (en:Method)
FR2498350B3 (en:Method)
FR2498271B1 (en:Method)
FR2498050B3 (en:Method)